These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 29617440)

  • 21. Effect of the introduction of pneumococcal conjugate vaccines on serotype prevalence in Kuwait and Saudi Arabia.
    Mokaddas EM; Shibl AM; Elgouhary A; Elsobky M
    Vaccine; 2018 Oct; 36(43):6442-6448. PubMed ID: 30194003
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of pneumococcal conjugate vaccine in children on the serotypic epidemiology of adult invasive pneumococcal diseases in Taiwan.
    Chi HC; Hsieh YC; Tsai MH; Lee CH; Kuo KC; Huang CT; Huang YC
    J Microbiol Immunol Infect; 2018 Jun; 51(3):332-336. PubMed ID: 28082066
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The impact of pneumococcal conjugate vaccines on carriage of and disease caused by Streptococcus pneumoniae serotypes 6C and 6D in southern Israel.
    Porat N; Benisty R; Givon-Lavi N; Trefler R; Dagan R
    Vaccine; 2016 May; 34(25):2806-12. PubMed ID: 27113163
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pneumococcal nasopharyngeal carriage in children <5 years of age visiting the pediatric emergency room in relation to PCV7 and PCV13 introduction in southern Israel.
    Ben-Shimol S; Givon-Lavi N; Greenberg D; Dagan R
    Hum Vaccin Immunother; 2016; 12(2):268-76. PubMed ID: 26430921
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Genomics of
    Sheppard CL; Groves N; Andrews N; Litt DJ; Fry NK; Southern J; Miller E
    Genes (Basel); 2019 Sep; 10(9):. PubMed ID: 31500179
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pneumococcal carriage and invasive disease in children before introduction of the 13-valent conjugate vaccine: comparison with the era before 7-valent conjugate vaccine.
    Sharma D; Baughman W; Holst A; Thomas S; Jackson D; da Gloria Carvalho M; Beall B; Satola S; Jerris R; Jain S; Farley MM; Nuorti JP
    Pediatr Infect Dis J; 2013 Feb; 32(2):e45-53. PubMed ID: 23080290
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prompt effect of replacing the 7-valent pneumococcal conjugate vaccine with the 13-valent vaccine on the epidemiology of invasive pneumococcal disease in Norway.
    Steens A; Bergsaker MA; Aaberge IS; Rønning K; Vestrheim DF
    Vaccine; 2013 Dec; 31(52):6232-8. PubMed ID: 24176490
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of the pneumococcal conjugate vaccines on invasive pneumococcal disease in France, 2001-2012.
    Lepoutre A; Varon E; Georges S; Dorléans F; Janoir C; Gutmann L; Lévy-Bruhl D; ;
    Vaccine; 2015 Jan; 33(2):359-66. PubMed ID: 25448105
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interim results of an ecological experiment - Conjugate vaccination against the pneumococcus and serotype replacement.
    Hausdorff WP; Hanage WP
    Hum Vaccin Immunother; 2016; 12(2):358-74. PubMed ID: 26905681
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Carriage of Haemophilus influenzae is associated with pneumococcal vaccination in Italian children.
    Camilli R; Vescio MF; Giufrè M; Daprai L; Garlaschi ML; Cerquetti M; Pantosti A
    Vaccine; 2015 Aug; 33(36):4559-64. PubMed ID: 26190092
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epidemiological and molecular characterization of invasive Streptococcus pneumoniae isolated following introduction of 7-valent conjugate vaccine in Kinki region, Japan, 2008-2013.
    Toda H; Tanaka Y; Satoh K; Komatsu M; Wada Y; Tobe T; Kamisako T
    J Infect Chemother; 2020 May; 26(5):451-458. PubMed ID: 31870586
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pneumococcal serotype evolution in Western Europe.
    Tin Tin Htar M; Christopoulou D; Schmitt HJ
    BMC Infect Dis; 2015 Oct; 15():419. PubMed ID: 26468008
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Measuring the effects of pneumococcal conjugate vaccine (PCV7) on Streptococcus pneumoniae carriage and antibiotic resistance: the Palestinian-Israeli Collaborative Research (PICR).
    Daana M; Rahav G; Hamdan A; Thalji A; Jaar F; Abdeen Z; Jaber H; Goral A; Huppert A; Raz M; Regev-Yochay G;
    Vaccine; 2015 Feb; 33(8):1021-6. PubMed ID: 25593104
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of 13-valent pneumococcal conjugate vaccine (PCV13) versus that of 7-valent PCV (PCV7) against nasopharyngeal colonization of antibiotic-nonsusceptible Streptococcus pneumoniae.
    Dagan R; Juergens C; Trammel J; Patterson S; Greenberg D; Givon-Lavi N; Porat N; Gurtman A; Gruber WC; Scott DA
    J Infect Dis; 2015 Apr; 211(7):1144-53. PubMed ID: 25355940
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changes in Streptococcus pneumoniae serotypes in the nasopharynx of Japanese children after inoculation with a heptavalent pneumococcal conjugate vaccine.
    Ueno M; Ishii Y; Tateda K; Anahara Y; Ebata A; Iida M; Mizuno F; Inamura S; Takahata K; Suzuki Y; Chang B; Wada A; Sugita M; Tanaka T; Nishiwaki Y
    Jpn J Infect Dis; 2014; 67(1):40-3. PubMed ID: 24451100
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Emerging Streptococcus pneumoniae Strains Colonizing the Nasopharynx in Children After 13-valent Pneumococcal Conjugate Vaccination in Comparison to the 7-valent Era, 2006-2015.
    Kaur R; Casey JR; Pichichero ME
    Pediatr Infect Dis J; 2016 Aug; 35(8):901-6. PubMed ID: 27420806
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibiotic-resistant Streptococcus pneumoniae in the heptavalent pneumococcal conjugate vaccine era: predictors of carriage in a multicommunity sample.
    Finkelstein JA; Huang SS; Daniel J; Rifas-Shiman SL; Kleinman K; Goldmann D; Pelton SI; DeMaria A; Platt R
    Pediatrics; 2003 Oct; 112(4):862-9. PubMed ID: 14523178
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epidemiological and molecular characterization of Streptococcus pneumoniae carriage strains in pre-school children in Arkhangelsk, northern European Russia, prior to the introduction of conjugate pneumococcal vaccines.
    Vorobieva S Jensen V; Furberg AS; Slotved HC; Bazhukova T; Haldorsen B; Caugant DA; Sundsfjord A; Valentiner-Branth P; Simonsen GS
    BMC Infect Dis; 2020 Apr; 20(1):279. PubMed ID: 32293324
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pneumococcal population in the era of vaccination: changes in composition and the relation to clinical outcomes.
    Elberse KE; Wagenvoort GH; Pluister GN; de Melker HE; Sanders EA; van der Ende A; Knol MJ
    Future Microbiol; 2016; 11(1):31-41. PubMed ID: 26673757
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharyngeal colonization by Streptococcus pneumoniae in older children and adolescents in a geographical area characterized by relatively limited pneumococcal vaccination coverage.
    Principi N; Terranova L; Zampiero A; Montinaro V; Ierardi V; Peves Rios W; Pelucchi C; Esposito S
    Pediatr Infect Dis J; 2015 Apr; 34(4):426-32. PubMed ID: 25760567
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.